Stockscreener 앱 받기
1.31
2.24%
-0.03
전일 마감가:
$1.34
열려 있는:
$1.3
하루 거래량:
108.30K
Relative Volume:
0.09
시가총액:
$129.82M
수익:
$624.29M
순이익/손실:
$6.86M
주가수익비율:
17.99
EPS:
0.0728
순현금흐름:
$-74.35M
1주 성능:
-10.88%
1개월 성능:
-39.35%
6개월 성능:
-69.18%
1년 성능:
-55.44%
1일 변동 폭
$1.30
$1.33
1주일 범위
$1.23
$1.47
52주 변동 폭
$1.23
$5.675
Docgo Inc Stock (DCGO) Company Profile
명칭
Docgo Inc
전화
(844) 443-6246
주소
685 THIRD AVENUE, NEW YORK
DCGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
1.31 | 138.75M | 624.29M | 6.86M | -74.35M | 0.0728 |
|
HCA
Hca Healthcare Inc
|
375.46 | 92.74B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
160.58 | 15.24B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
118.31 | 12.07B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
185.50 | 12.62B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
136.91 | 10.85B | 12.82B | 936.34M | 1.47B | 10.74 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-08-18 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-01-19 | 개시 | Stifel | Buy |
| 2021-12-21 | 개시 | Canaccord Genuity | Buy |
| 2021-12-07 | 개시 | Needham | Buy |
모두보기
Docgo Inc 주식(DCGO)의 최신 뉴스
DocGo stock touches 52-week low at $1.35 amid market challenges - Investing.com
DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program - 01net
(DCGO) Technical Data - news.stocktradersdaily.com
Insider Buying: Michael Burdiek Acquires 15,000 Shares of DocGo Inc (DCGO) - GuruFocus
DocGo Inc. (NASDAQ:DCGO) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough - simplywall.st
Insider Buying: Klasko Stephen K. M.D. Acquires 15,000 Shares of DocGo Inc (DCGO) - GuruFocus
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm - GlobeNewswire
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm - GlobeNewswire Inc.
DocGo Executives and Director Make Significant Stock Purchases - TradingView
DocGo (DCGO) Faces Downgrade as Canaccord Lowers Price Target | - GuruFocus
DocGo (DCGO) Price Target Reduced as Revenue Forecast Adjusted | - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Analyst Expectations For DocGo's Future - Benzinga
DocGo (DCGO) Downgraded to Hold by Canaccord Genuity | DCGO Stock News - GuruFocus
DocGo (DCGO) Faces Downgrade as Canaccord Lowers Price Target | DCGO Stock News - GuruFocus
BTIG Research Downgrades DocGo to Neutral From Buy - marketscreener.com
Canaccord Genuity Downgrades DocGo to Hold From Buy, Adjusts Price Target to $1.45 From $5 - marketscreener.com
DocGo First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
DocGo Inc. (NASDAQ:DCGO) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG cuts DocGo stock rating following weak Q1 results By Investing.com - Investing.com South Africa
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates - MSN
DocGo, Inc. Earnings Call: Growth Amid Challenges - TipRanks
DocGo (DCGO): Analyst Maintains Rating, Lowers Price Target | DC - GuruFocus
DocGo (DCGO): Analyst Maintains Rating, Lowers Price Target | DCGO Stock News - GuruFocus
DocGo (DCGO) Price Target Reduced by Analyst Following Earnings Miss | DCGO Stock News - GuruFocus
BTIG cuts DocGo stock rating following weak Q1 results - Investing.com
DocGo downgraded to Neutral from Buy at BTIG - TipRanks
DocGo (DCGO) Faces Downgrade Amid Revenue Concerns | DCGO Stock News - GuruFocus
DocGo Inc (DCGO) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: DocGo Q1 2025 results disappoint, stock plunges - Investing.com
DocGo Inc. Reports Q1 2025 Earnings Amid Strategic Shift - TipRanks
Earnings call transcript: DocGo Q1 2025 results disappoint, stock plunges By Investing.com - Investing.com India
DocGo Inc reports results for the quarter ended March 31Earnings Summary - TradingView
DocGo Inc Reports Q1 2025 Earnings: EPS of -$0.09 Misses Estimat - GuruFocus
DocGo Announces First Quarter 2025 Results - Business Wire
What To Expect From DocGo Inc (DCGO) Q1 2025 Earnings - GuruFocus
DocGo Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
DocGo Inc. (DCGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc.DCGO - Business Wire
Press Release Distribution & PR Platform - ACCESS Newswire
How the (DCGO) price action is used to our Advantage - news.stocktradersdaily.com
Dover Air Force Base instills new EMS provider - Bay to Bay News
DocGo to Announce First Quarter Results on Thursday, May 8, 2025 - 01net
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc.DCGO - The Malaysian Reserve
Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is It Too Late To Consider Buying DocGo Inc. (NASDAQ:DCGO)? - simplywall.st
DocGo stock touches 52-week low at $2.31 amid market shifts - Investing.com Australia
DocGo stock touches 52-week low at $2.31 amid market shifts By Investing.com - Investing.com South Africa
Docgo Inc (DCGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Docgo Inc 주식 (DCGO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Klasko Stephen K. M.D. | Director |
May 14 '25 |
Buy |
1.49 |
15,000 |
22,350 |
15,000 |
| Sugrue Stephen | Chief Compliance Officer |
May 14 '25 |
Buy |
1.44 |
10,000 |
14,400 |
357,328 |
| ROSENBERG NORMAN | CFO and Treasurer |
May 14 '25 |
Buy |
1.47 |
15,000 |
22,050 |
871,272 |
| Bienstock Lee | Chief Executive Officer |
May 14 '25 |
Buy |
1.54 |
15,000 |
23,100 |
1,971,079 |
0.62%
0.86%
자본화:
|
볼륨(24시간):